Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 11:54 PM
NCT ID:
NCT03123094
Pre Assignment Details:
All subjects were screened for eligibility to participate in the trial. Subjects attended specialist sites which would then ensure that all subjects met all inclusion/exclusion criteria. Subjects were not to be randomised to trial treatment if any one of the specific entry criteria were not met.
Dose level for each arm cannot be provided because the information is a combination of both commercially sensitive confidential information as well as proprietary information.
Recruitment Details:
This was a double-blind, randomised, and placebo-controlled trial of single rising intravenous (IV) doses and single subcutaneous (SC) doses of spesolimab (BI 655130) in healthy male Japanese subjects.
Study:
NCT03123094
Study Brief:
Results Section:
NCT03123094